Files
2026-07-06 17:27:20 -04:00

71 lines
3.1 KiB
Markdown
Raw Permalink Blame History

This file contains ambiguous Unicode characters
This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.
---
type: "Bill"
title: "State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders"
description: "State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders"
jurisdiction: "us/states/md"
legislature: "Maryland General Assembly"
session: "2026"
identifier: "SB 562"
citation: "Maryland SB 562 (2026)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Gile"]
version_count: 3
action_count: 13
vote_count: 2
first_action: "2026-02-04"
last_action: "2026-04-14"
source: "openstates"
source_identifier: "ocd-bill/f123f942-ccfe-4616-9aef-f8d5d3daff50"
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0562?ys=2026RS"
source_hash: "8cc110316cad18dcb82089eb10fe378534617b5a0578886783ec85da2a8d4b2c"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-md"]
---
# Maryland SB 562 (2026) — State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders
## Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
1. **Chapter - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/Chapters_noln/CH_54_sb0562t.pdf)
2. **First - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0562f.pdf)
3. **Third - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0562t.pdf)
## Votes
- On Third Reading — **450** (pass) · upper
- On Third Reading — **1320** (pass) · lower
## Sponsors
- Gile — primary (person)
## Timeline
The legislative action history — every referral, reading, and vote.
- **2026-02-04** First Reading Finance `referral-committee`
- **2026-02-12** Hearing 3/03 at 1:00 p.m.
- **2026-03-09** Favorable with Amendments Report by Finance `committee-passage-favorable`
- **2026-03-10** Favorable with Amendments { `committee-passage-favorable`
- **2026-03-10** Second Reading Passed with Amendments
- **2026-03-12** Third Reading Passed `passage`
- **2026-03-13** Referred Health `referral-committee`
- **2026-03-17** Hearing 3/25 at 1:00 p.m.
- **2026-04-01** Favorable Report by Health `committee-passage-favorable`
- **2026-04-01** Favorable Adopted Second Reading Passed `committee-passage-favorable`
- **2026-04-02** Third Reading Passed `passage`
- **2026-04-03** Returned Passed
- **2026-04-14** Approved by the Governor - Chapter 54 `executive-signature`
## Source
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/f123f942-ccfe-4616-9aef-f8d5d3daff50`. Confidence: reported (aggregated from official Maryland legislature records).